HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
Quote:
Login Free Membership
Search:

Analyst Blog  

HCP Prices Unsecured Notes

Share
By: Zacks Equity Research
January 19, 2012 | Comment(s): 0
Recommended this article (6)
HCP | HCN

HCP Inc (HCP - Analyst Report) recently announced the pricing of $450 million of 3.75% senior unsecured notes, scheduled to mature in 2019. The transaction is expected to generate net proceeds of approximately $443.7 million. HCP expects to utilize the proceeds to repay the debt under its revolving credit facility and for general corporate purposes. The offering is slated to close on January 23, 2012.

HCP has a conservative approach toward financial management given its active debt-to-equity management, coupled with efficient maintenance of  multiple sources of liquidity like revolving credit facility, access to capital markets and secured debt providers, and divesture of assets. The financial flexibility enables the company to seize potential investment opportunities. At quarter end, the company had cash and cash equivalents of $44.9 million.

HCP reported FFO (funds from operations) of $259.6 million or 63 cents per share in the third quarter of 2011 compared with $96.1 million or 31 cents per share in the year-earlier quarter. Funds from operations, a widely used metric to gauge the performance of REITs, is obtained after adding depreciation and amortization and other non-cash expenses to net income.

HCP is the leading medical REIT in the US with one of the largest and most diversified portfolios in the healthcare sector with exposure to all types of facilities. The product diversity of the company allows it to capitalize on opportunities in different markets based on individual market dynamics, and provides a hard-to-replicate competitive advantage over its peers.

HCP currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We are also maintaining our long-term Neutral recommendation on the stock. One of its competitors, Health Care REIT, Inc. (HCN - Analyst Report) holds a Zacks #2 Rank, which implies a short-term Buy rating.

Read the full analyst report on HCP

Read the full analyst report on HCN

 

Please login to Zacks.com or register to post a comment.



Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
7 Best Stocks for the Next 30 Days
Get your free Welcome Gifts today*:
 1.  Special Report with best short-term Zacks recommendations from the list that averages a gain of +26% per year
 2.  Our free e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 26, 2012 17:26 pm ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center